Skip to main content


You are here

NYT: 2 New Ebola Vaccines Pass Important Early Test, Researchers Say

Wednesday, April 8, 2015

Vaccines Made by Profectus BioSciences

Two new Ebola vaccines have passed an important test, protecting monkeys against the strain of the virus responsible for the current deadly outbreak, researchers reported on Wednesday. Only one dose was needed, and there were no apparent side effects.

The vaccines have not yet been tested in people, but safety trials in healthy volunteers will probably begin early this summer, said Thomas W. Geisbert, an Ebola expert at the University of Texas Medical Branch in Galveston, and the senior author of a report published on Wednesday in the journal Nature.

Read more from The New York Times.

Click here to read the related Profectus press release.